B. Sassolas

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

B. Sassolas, Cynthia Haddad, Maja Mockenhaupt et al. · Clinical Pharmacology & Therapeutics · 2010 · 707 citations

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

Jürgen Schneck, Jean‐Paul Fagot, Peggy Sekula et al. · Journal of the American Academy of Dermatology · 2007 · 456 citations

Toxic Epidermal Necrolysis, Prospective Euroscar Study, Stevens-johnson Syndrome +2

Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases

Jean‐Jacques Grob, Brigitte Dréno, Pauline de La Salmonière et al. · The Lancet · 1998 · 435 citations

Surgical Oncology, Detectable Node Metastases, Medicine +6

A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou et al. · Journal of Investigative Dermatology · 2009 · 238 citations · Full text

Bullous Pemphigoid, Clinical Dermatology, Dermatology +4